Filing Details
ARTELO BIOSCIENCES, INC. (NASDAQ:ARTL) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event.
8k filedNASDAQ:ARTL
ARTELO BIOSCIENCES, INC. (ARTL) Reports Material Event to SEC
Filing Details ARTELO BIOSCIENCES, INC. (NASDAQ:ARTL) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event. Market Context…
Market Context
ARTELO BIOSCIENCES, INC.'s stock currently trades at $1.15 with a market capitalization of $2.8M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for ARTELO BIOSCIENCES, INC.'s stock.
All SEC filings for ARTELO BIOSCIENCES, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ARTL Stock Page
Frequently Asked Questions
Where can I read ARTL's SEC filings?
Browse all filings on our ARTL SEC filings page.
What types of SEC filings does ARTELO BIOSCIENCES, INC. file?
Public companies like ARTELO BIOSCIENCES, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.